Cargando…

Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Swiss National Science Foundation BACKGROUND: Pulmonary vein isolation (PVI) is the cornerstone interventional treatment for AF. While this strategy is effective in paroxysmal AF, the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Prudat, Y, Luca, A, Derval, N, Jais, P, Roten, L, Kobza, R, Berte, B, Le Bloa, M, Herrera-Siklody, C, Teres, C, Pruvot, E, Vesin, J M, Pascale, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206730/
http://dx.doi.org/10.1093/europace/euad122.006
_version_ 1785046292820393984
author Prudat, Y
Luca, A
Derval, N
Jais, P
Roten, L
Kobza, R
Berte, B
Le Bloa, M
Herrera-Siklody, C
Teres, C
Pruvot, E
Vesin, J M
Pascale, P
author_facet Prudat, Y
Luca, A
Derval, N
Jais, P
Roten, L
Kobza, R
Berte, B
Le Bloa, M
Herrera-Siklody, C
Teres, C
Pruvot, E
Vesin, J M
Pascale, P
author_sort Prudat, Y
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Swiss National Science Foundation BACKGROUND: Pulmonary vein isolation (PVI) is the cornerstone interventional treatment for AF. While this strategy is effective in paroxysmal AF, the success rate of this approach is more limited in persistent AF (PsAF). In these pts, the main challenge is to discriminate those who will respond to PVI only, from those who may require an extended ablation strategy. PURPOSE: We aimed to evaluate whether the analysis of the electrical activity recorded within the PV may provide the key to discriminate passive PV from PV playing an active role. METHODS: Three-subgroups of consecutive pts who underwent first-time PVI for PsAF were considered based on the mechanism of AF: 1) definitely related to PV, based on procedural AF termination during PVI (the "PV-term" group) 2) likely PV-dependent, based on the absence of AF recurrence > 18 months off-antiarrhythmic drugs after PVI only (the "PV-dep" group) 3) definitely/likely independent of the PV, based on PsAF recurrence despite isolated PV or at least one redo consisting of PV reisolation only, respectively ("PV-indep"). PV activity during AF was assessed using Lasso recordings before ablation. An automatic detection algorithm was developed to extract atrial activations from intra-cardiac electrograms in order to perform further analyses. Epochs of 60-sec were used. Different methods based on the atrial cycle length variability were assessed to best characterize the potential markers of PV activity such as the occurrence of intermittent bursts of rapid activity. Each PV and the left atrial appendage (LAA) were evaluated. RESULTS: A total of 40 pts were included (mean age: 60.0 ± 9.9 years, mean PsAF duration: 4.4 ± 4.3 years) (PV-term group (n=10), PV-dep group (n=17), PV-indep group (n= 13)). The dynamics of PV activation intervals was assessed using the envelope of the PV intervals time series (Figure 1A shows representative examples of each group). Among all features evaluated, the best feature that could discriminate similarly both the PV-term and the PV-dep group from the PV-indep group, was the standard deviation of the inferior envelope relative to the median CL of the vein (p <0.001 and p = 0.005, respectively) (Figure 1B). Cut-off selected by ROC analysis provided a 100% sensitivity and 85% specificity to discriminate the PV-term from the PV-indep group (AUC 0.931) and a 88% sensitivity and 77% specificity to discriminate the PV-dep from the PV-indep group (AUC 0.805). We compared this feature with the Fastest PV run (mean CL of the fastest 10-beat run) as recently described (p = 0.04, AUC = 0.762 and p = 0.03, AUC = 0.738, respectively) (Figure 2). CONCLUSIONS: The assessment of the CL variations recorded within the PV before PsAF ablation may provide the key to discriminate pts who may be cured by PVI only. [Figure: see text] [Figure: see text]
format Online
Article
Text
id pubmed-10206730
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102067302023-05-25 Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF Prudat, Y Luca, A Derval, N Jais, P Roten, L Kobza, R Berte, B Le Bloa, M Herrera-Siklody, C Teres, C Pruvot, E Vesin, J M Pascale, P Europace 10.1.6 - Defining Types of Atrial Fibrillation FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Swiss National Science Foundation BACKGROUND: Pulmonary vein isolation (PVI) is the cornerstone interventional treatment for AF. While this strategy is effective in paroxysmal AF, the success rate of this approach is more limited in persistent AF (PsAF). In these pts, the main challenge is to discriminate those who will respond to PVI only, from those who may require an extended ablation strategy. PURPOSE: We aimed to evaluate whether the analysis of the electrical activity recorded within the PV may provide the key to discriminate passive PV from PV playing an active role. METHODS: Three-subgroups of consecutive pts who underwent first-time PVI for PsAF were considered based on the mechanism of AF: 1) definitely related to PV, based on procedural AF termination during PVI (the "PV-term" group) 2) likely PV-dependent, based on the absence of AF recurrence > 18 months off-antiarrhythmic drugs after PVI only (the "PV-dep" group) 3) definitely/likely independent of the PV, based on PsAF recurrence despite isolated PV or at least one redo consisting of PV reisolation only, respectively ("PV-indep"). PV activity during AF was assessed using Lasso recordings before ablation. An automatic detection algorithm was developed to extract atrial activations from intra-cardiac electrograms in order to perform further analyses. Epochs of 60-sec were used. Different methods based on the atrial cycle length variability were assessed to best characterize the potential markers of PV activity such as the occurrence of intermittent bursts of rapid activity. Each PV and the left atrial appendage (LAA) were evaluated. RESULTS: A total of 40 pts were included (mean age: 60.0 ± 9.9 years, mean PsAF duration: 4.4 ± 4.3 years) (PV-term group (n=10), PV-dep group (n=17), PV-indep group (n= 13)). The dynamics of PV activation intervals was assessed using the envelope of the PV intervals time series (Figure 1A shows representative examples of each group). Among all features evaluated, the best feature that could discriminate similarly both the PV-term and the PV-dep group from the PV-indep group, was the standard deviation of the inferior envelope relative to the median CL of the vein (p <0.001 and p = 0.005, respectively) (Figure 1B). Cut-off selected by ROC analysis provided a 100% sensitivity and 85% specificity to discriminate the PV-term from the PV-indep group (AUC 0.931) and a 88% sensitivity and 77% specificity to discriminate the PV-dep from the PV-indep group (AUC 0.805). We compared this feature with the Fastest PV run (mean CL of the fastest 10-beat run) as recently described (p = 0.04, AUC = 0.762 and p = 0.03, AUC = 0.738, respectively) (Figure 2). CONCLUSIONS: The assessment of the CL variations recorded within the PV before PsAF ablation may provide the key to discriminate pts who may be cured by PVI only. [Figure: see text] [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10206730/ http://dx.doi.org/10.1093/europace/euad122.006 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 10.1.6 - Defining Types of Atrial Fibrillation
Prudat, Y
Luca, A
Derval, N
Jais, P
Roten, L
Kobza, R
Berte, B
Le Bloa, M
Herrera-Siklody, C
Teres, C
Pruvot, E
Vesin, J M
Pascale, P
Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF
title Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF
title_full Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF
title_fullStr Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF
title_full_unstemmed Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF
title_short Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF
title_sort patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent af
topic 10.1.6 - Defining Types of Atrial Fibrillation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206730/
http://dx.doi.org/10.1093/europace/euad122.006
work_keys_str_mv AT prudaty patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT lucaa patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT dervaln patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT jaisp patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT rotenl patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT kobzar patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT berteb patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT lebloam patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT herrerasiklodyc patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT teresc patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT pruvote patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT vesinjm patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf
AT pascalep patternsofpulmonaryveinactivitythatmayhelpidentifypatientswhoneedfurtherablationbeyondpulmonaryveinisolationinpersistentaf